Correlation between microsatellite instability and morphology in colorectal cancer;A microsatellita-státus és a morfológiai kép összefüggése vastagbélrákokban

Magyar Onkologia

Volumn 54, Issue 2, 2010, Pages 169-178

  Szentirmay, Zoltán ^a   Gallai, Mónika ^a   Serester, Orsolya ^a   Szoke, János ^a   Tóth, Erika ^a  

^a NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

Author keywords

clinicopathologically based genetic prediction; Colorectal carcinoma; microsatellite instability; tumor morphology

Indexed keywords

CANCER STAGING; CLINICAL FEATURE; COLORECTAL CANCER; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HISTOPATHOLOGY; HUMAN; MICROSATELLITE INSTABILITY; NUCLEOLUS; REVIEW; TUMOR ASSOCIATED LEUKOCYTE; TUMOR LOCALIZATION;

ADULT; AGED; COLORECTAL NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; FEMALE; HUMANS; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS;

EID: 77954116847     PISSN: 00250244     EISSN: 20600399     Source Type: Journal    
DOI: 10.1556/MOnkol.54.2010.2.12     Document Type: Review

References (44)

1. Alexander J, Watanabe T, Wu TT, et al. Histopathologic identification of colon cancer with microsatellite instability. Am J Pathol 158:527-535, 2001
2. Arai T, Esaki Y, Sawabe M, et al. Hypermethylation of the hMLH1 promoter with absent hMLH1 expression in medullary-type poorly diff erentiated colorectal adenocarcinoma in the elderly. Mod Pathol 17:172-179, 2004
3. Banerjea A, Ahmed S, Hands RE, et al. Colorectal cancers with microsatellite instability display mRNA expression signatures characteristic of increased immunogenicity. Mol Cancer 3:21, 2004
4. Boland CR, Thibodeau SN, Hamilton SR, et al. A National Cancer Institute Workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58:5248-5257, 1998
5. de la Chapelle A. Microsatellite instability. N Engl J Med 349:209-210, 2003
6. Ding L, Getz G, Wheeler DA. Somatic mutations aff ect key pathways in lung adenocarcinoma. Nature 455:1069-1075, 2008
7. Dietmaier W, Hofstadter F. Detection of microsatellite instability by real time PCR and hybridization probe melting point analysis. Lab Invest 81:1453-1456, 2001
8. Dixon WJ (ed.). BMDP Statistical Soft ware, Inc. Release 7, University of California Press, Berkeley, Los Angeles, Oxford, 1992
9. Duval A, Hamelin R. Mutations at coding repeat sequences in mismatch repair-defi cient human cancers: toward a new concept of target genes for instability. Cancer Res 62:2447-2454, 2002
10. Gafà R, Maestri I, Matt euzzi M, et al. Sporadic colorectal adenocarcinomas with high-frequency microsatellite instability. Pathobiologic features, hMLH1 and hMSH2 expression, and clinical outcome. Cancer 89:2025-2037, 2000
11. Goeck e T, Sch ulmann K, Engel C, et al. Genotype-phenotype comparison of German MLH1 and MSH2 mutation carriers clinically aff ected with Lynch syndrome: a report by the German HNPCC Consortium. J Clin Oncol 24:4285-4292, 2006
12. Greenson JK, Bonner JD, Ben-Yzhak O. Phenotype of microsatellite unstable colorectal carcinomas. Well-diff erentiated and focally mucinous tumors and the absence of dirty necrosis correlate with microsatellite instability. Am J Surg Pathol 27:563-570, 2003
13. Hoang J-M, Cott u PH, Thuille B, et al. BAT-26, an indicator of replication error phenotype in colorectal cancers and cell lines. Cancer Res 57:300-303, 1997
14. Ichikawa A, Sugano K, Fujita S. DNA variants of BAT-25 in Japanese, a locus frequently used for analysis of microsatellite instability. Jpn J Clin Oncol 31:346-348, 2001
15. Jass JR. HNPCC and sporadic MSI-H colorectal cancer: review of the morphological similarities and diff erences. Fam Cancer 3:93-100, 2004
16. Jass JR. Classifi cation of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology 50:113-130, 2007
17. Kobayashi C, Monforte-Munoz HL, Gerbing RB, et al. Enlarged and prominent nucleoli may be indicative of MYCN amplifi cation. Cancer 103:174-181, 2005
18. Kuismanen SA, Holmberg MT, Salovaara R, et al. Epigenetic phenotypes distinguish microsatellite-stable and-unstable colorectal cancers. Proc Natl Acad Sci USA 96:12661-12666, 1999
19. Lanza G, Gafà R, Matt euzzi M, Santini A. Medullary-type poorly diff erentiated adenocarcinoma of the large bowel: a distinct clinicopathologic entity characterized by microsatellite instability and improved survival. J Clin Oncol 17:2429-2438, 1999
20. Lynch HT, de la Chapelle A. Hereditary colorectal cancer. N Engl J Med 348:919-932, 2003
21. Markowitz S, Wang J, Myeroff L, et al. Inactivation of the type II TGF-α receptor in colon cancer cells with microsatellite instability. Science 268:1336-1338, 1995
22. Miett inen M. From morphological to molecular diagnosis of soft tissue tumors. In: New Trends in Cancer for the 21st Century. Eds. López- Guerrero JA, et al. Springer, Berlin-Heidelberg 2006, pp. 99-113
23. Myeroff LL, Parsons R, Kim SJ, et al. A transforming growth factor β type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability. Cancer Res 55:5545-5547, 1995
24. Ogino S, Kawasaki T, Kirkner GJ, et al. Molecular correlates with MGMT promoter methylation and silencing support CpG island methylator phenotype-low (CIMP-low) in colorectal cancer. Gut 56:1564-1571, 2007
25. Ogino S, Goel A. Molecular classifi cation and correlates in colorectal cancer. J Mol Diagn 10:13-27, 2008
26. Parsons R, Myeroff LL, Liu B, et al. Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer. Cancer Res 55:5548-5550, 1995
27. Pasterello C, Baglioni S, Tibilett i MG, et al. Stability of BAT-26 marker in tumours of hereditary nonpolyposis colorectal cancer patients with MSH2 intragenic deletion. Eur J Hum Genet 15:139-141, 2007
28. Pao W, Miller V, Zakowsky M. EGF receptor gene mutations are common in lung cancer from .,never-smokers" and are associated with sensitivity of tumors to gefi nitib and erlotinib. Proc Natl Acad Sci USA 101:13306-13311, 2004
29. Ribic CM, Sargent DJ, Moore MJ, et al. Tumor microsatellite-instability status as a predictor of benefi t from fl uorouracil-based adjuvant chemotherapy for colon cancer. New Engl J Med 349:247-257, 2003
30. Rosai J. The continuing role of morphology in the molecular age. Mod Pathol 14:258-260, 2001
31. Rüschoff J, Dietmaier W, Lütt ges J, et al. Poorly diff erentiated colonic adenocarcinoma, medullary type: clinical, phenotypic, and molecular characteristics. Am J Pathol 150:1815-1825, 1997
32. Schneikert J, Behrens J. The canonical Wnt signalling pathway and its APC partner in colon cancer development. Gut 56:417-425, 2007
33. Shia J, Ellis NA, Philip B, Paty PB, et al. Value of histopathology in predicting microsatellite instability in hereditary nonpolyposis colorectal cancer and sporadic colorectal cancer. Am J Surg Pathol 27:1407-1417, 2003
34. Szentirmay Z, Szakács O, Gallai M. Morfológia és molekuláris patológia összefüggése vastagbélrákban. 66. Patológus Kongreszszus, Balatonfüred, 2007
35. Sžke J, Csernák E, Szentirmay Z. Mutational analysis of the epidermal growth factor receptor gene in clinical samples of adenocarcinoma of the lung. Revis Med Farmac 54(Suppl 3):495-498, 2008
36. Takemoto N, Konishi F, Yamashita K, et al. The correlation of microsatellite instability and tumor-infi ltrating lymphocytes in hereditary non-polyposis colorectal cancer (HNPCC) and sporadic colorectal cancers: the signifi cance of diff erent types of lymphocyte infi ltration. Jpn J Clin Oncol 34:90-98, 2004
37. Tomlinson I, Halford S, Aaltonen L, et al. Does MSI-low exist? J Pathol 197:6-13, 2002
38. Tornóczky T, Semjén D, Shimada H, Ambros IM. Pathology of peripheral neuroblastic tumors: signifi cance of prominent nucleoli in undiff erentiated/poorly diff erentiated neuroblastoma. Pathol Oncol Res 13:269-275, 2007
39. Umar AC, Boland R, Terdiman JP, et al. Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 96:261-268, 2004
40. Wagner A, van Kessel I, Kriege MG, et al. Long term follow-up of HNPCC gene mutation carriers: compliance with screening and satisfaction with counseling and screening procedures. Fam Cancer 4:295-300, 2005
41. Wang J, Sun L, Myeroff L, et al. Demonstration that mutation of the type II transforming growth factor β receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells. J Biol Chem 270:22044-22049, 1995
42. Weinberg RA. Maintenance of genomic integrity and the development of cancer. In: The Biology of Cancer. Garland Science. Taylor & Francis Group, LLC, New York and Abingdon 2007, pp. 463-526
43. van de Wetering M, Sancho E, Verwé C, et al. The beta-catenin/ TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 111:241-250, 2002
44. Whitehall V L, Walsh M D, Young J, et al. Methylation of O-6-methylguanine DNA methyltransferase characterizes a subset of colorectal cancer with low-level DNA microsatellite instability. Cancer Res 61:827-830, 2001